Conflict of Interest
China Oncology complies with the International Committee of Medical Journal Editors' uniform requirements on Conflict of Interest statement.
Conflict of Interest exists when an author (or the author’s institution), reviewer, or editor has financial or personal relationships with other persons or organizations that inappropriately influence (bias) his or her actions. The existence of such relationships does not necessarily represent true conflict of interest. The potential for conflict of interest can exist whether or not an individual believes that the relationship affects their judgment. Financial relationships (such as employment, consultancies, stock ownership, honoraria, paid expert testimony, patents) are the most easily identifiable conflicts of interest and the most likely to undermine the credibility of the journal, the authors, and of science itself (http://www.icmje.org/index.html).
All participants in the peer-review and publication process—not only authors but also peer reviewers, editors, and editorial board members of journals—must consider their conflicts of interest when fulfilling their roles in the process of article review and publication and must disclose all relationships that could be viewed as potential conflicts of interest.
When authors submit a manuscript of any type or format they are responsible for disclosing all financial and personal relationships that might bias or be seen to bias their work.
b. Peer Reviewers
Reviewers should be asked at the time they are asked to critique a manuscript if they have conflicts of interest that could complicate their review. Reviewers must disclose to editors any conflicts of interest that could bias their opinions of the manuscript, and should recuse themselves from reviewing specific manuscripts if the potential for bias exists. Reviewers must not use knowledge of the work they’re reviewing before its publication to further their own interests.
c. Editors and Journal Staff
Editors who make final decisions about manuscripts should recuse themselves from editorial decisions if they have conflicts of interest or relationships that pose potential conflicts related to articles under consideration. Other editorial staff members who participate in editorial decisions must provide editors with a current description of their financial interests or other conflicts (as they might relate to editorial judgments) and recuse themselves from any decisions in which a conflict of interest exists. Editorial staff must not use information gained through working with manuscripts for private gain. Editors should publish regular disclosure statements about potential conflicts of interests related to the commitments of journal staff. Guest editors should follow these same procedures.
2. Reporting Conflicts of Interest
Articles should be published with statements or supporting documents, declaring:
● Authors’ conflicts of interest;
● Sources of support for the work, including sponsor names along with explanations of the role of those sources if any in study design; collection, analysis, and interpretation of data; writing of the report; the decision to submit the report for publication; or a statement declaring that the supporting source had no such involvement;
● Whether the authors had access to the study data, with an explanation of the nature and extent of access, including whether access is on-going.
To support the above statements, editors may request that authors of a study sponsored by a funder with a proprietary or financial interest in the outcome sign a statement, such as “I had full access to all of the data in this study and I take complete responsibility for the integrity of the data and the accuracy of the data analysis.”
Human and Animal Rights
When reporting experiments on human subjects, authors should indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national). If doubt exists whether the research was conducted in accordance with the ethical standards, the authors must explain the rationale for their approach, and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. When reporting experiments on animals, authors should be asked to indicate whether the institutional and national guide for the care and use of laboratory animals was followed.
Identifying information, including names, initials, or hospital numbers, should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent is required for Case report, original/research articles and visualized surgery. The statement should be included in the footnote.
It may be possible to publish without explicit consent if the report is important to public health (or is in some other way important); consent would be unusually burdensome to obtain; and a reasonable individual would be unlikely to object to publication (all three conditions must be met).
● conception and design of the study, acquisition of the data, or analysis and interpretation of the data;
● drafting of the article or critical revision of the article for important intellectual content;● final approval of the version to be submitted. When authorship is attributed to a group, all authors must meet the listed criteria and must be responsible for the quality, accuracy, and ethics of the work. All authors must participate in determining the order of authorship.
Publishing permission of illustrationsIf all or parts of previously published illustrations are used, permission must be obtained from the source publications.
Preparation of manuscriptManuscripts must be written in Chinese with English abstract or in English with Chinese abstract. The manuscripts should be formatted in DOC file with A4 paper size, 1.5-line spacing, single column, and wide margin. All pages should be numbered consecutively in the bottom right-hand corner, beginning with the first page.
All the references should be written in English, if the non-English references should be translated into English script; then this should be alongside the original references in non-English script.
Submission of manuscript
The manuscript can be submitted online http://www.china-oncology.com
Peer Review Process and acceptance
The acceptance criteria for all articles are the quality and originality of the research and its significance to readership. All manuscripts are peer reviewed by at least two anonymous reviewers (i.e. single blind peer review), and the final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication. Authors are encouraged to suggest three to five qualified reviewers. Decisions on acceptance, revision, or rejection are made within two to four months of submission commonly. Papers are usually published in chronological order of acceptance. The editors reserve the right to modify typescripts to eliminate ambiguity and repetition. If extensive alterations are required, the manuscript will be returned to the author for revision.
Data sharing policy
China Oncology promotes and allows you to share data that supports the publication of studies when necessary and allows you to interlink the data with your published articles. Research data refers to the results of the observations or experimentation that confirm the research findings. The journal promotes the writers of articles published in our journal to share their research data including, but not limited to raw data, processed data, software, algorithms, protocols, models, methods and other related materials.
To follow the policy, you can link your article directly to the dataset if you have made your study data accessible in a data repository. Meanwhile, China Oncology encourages writers to provide their manuscript with a data statement. Data sharing statements may indicate whether individual de-identified participant data (including data dictionaries) will be shared (“undecided” is not an acceptable answer) or what data, in particular, will be shared. Also it may indicate whether additional, related documents will be available (e.g., study protocol, statistical analysis plan, etc.) as well as when the data will become available and for how long and by what access criteria data will be shared (including with whom, for what types of analyses, and by what mechanism).
Papers submitted for the column of the Guideline, Specialist's Commentary and Article, are free of publication fee. For innovative articles recommended by the reviewers, China Oncology provides a waiver or discount on publication fees for authors
The Ministry of Education of the People’s Republic of China
Fudan University Shanghai Cancer Center
Editorial Board of China Oncology
TANG Zhaoyou, CAO Shilong
Shanghai Ouyang Printing Co., Ltd.